Saturday 17 October 2026
Export BVS’s income statement to Excel — free account
Bioventus Inc.
BVS Healthcare Medical Devices
Bioventus Inc.’s revenue for fiscal 2025 (year ended December 2025) was $568.1 million, down 0.91% from fiscal 2024. In the quarter to June 2026, revenue grew 3.76%, EPS grew 345.5%, free cash flow fell 25.1% and total debt fell 27.2%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
13.30
0.51
−3.69%
Follow BVS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
21.88 | 0.00 | 0.00 | 0.00 | 32.43 | 21.92 | 21.92 | 21.92 | 21.92 | 21.92 |
Piotroski F-Score |
8 | 5 | 4 | 2 | 4 | — | — | — | — | — |
Altman Z-Score |
1.26 | 0.89 | 0.22 | (0.12) | 1.03 | — | — | — | — | — |
P/S ratio |
0.87 | 1.18 | 0.64 | 0.31 | 1.53 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
Altman Z″-Score (non-manufacturers) |
0.54 | (0.79) | (0.83) | (0.91) | 1.30 | 0.95 | 1.24 | — | — | — |
P/FCF ratio |
6.87 | 17.94 | 41.21 | 0.00 | 69.57 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 |
P/Operating CF |
13.06 | 35.08 | 31.70 | 30.55 | 50.23 | 3.70 | 3.70 | 3.70 | 3.70 | 3.70 |
Beneish M-Score |
(2.77) | (3.08) | (3.52) | (2.87) | (1.86) | (3.01) | — | — | — | — |
P/B ratio |
2.17 | 3.65 | 1.49 | 0.39 | 1.23 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.30 | 1.70 | 1.34 | 1.07 | 2.25 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 |
EV/EBITDA |
7.31 | 28.28 | 0.00 | 0.00 | 20.61 | 3.88 | 3.88 | 3.88 | 3.88 | 3.88 |
EV/Operating CF |
9.89 | 25.05 | 44.76 | (40.49) | 42.08 | 2.73 | 2.73 | 2.73 | 2.73 | 2.73 |
EV/FCF |
10.24 | 25.72 | 86.04 | (36.50) | 102.14 | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 |
Quick Ratio |
1.12 | 0.80 | 0.91 | 0.55 | 0.96 | 1.43 | 1.68 | 1.78 | — | — |
Current Ratio |
1.70 | 1.31 | 1.53 | 0.90 | 1.45 | 1.73 | 2.06 | 2.28 | — | — |
Net Debt/EBITDA |
2.40 | 8.56 | (14.69) | (3.47) | 6.57 | 2.04 | 2.17 | 2.69 | 0.00 | 0.00 |
Debt/Assets |
43.00% | 46.11% | 48.69% | 30.46% | 29.18% | 38.10% | 41.91% | 0.00% | 0.00% | — |
Debt/Equity |
1.29 | 1.81 | 1.79 | 1.01 | 0.67 | 1.31 | 1.36 | 0.00 | 0.00 | — |
Asset Turnover |
0.80 | 0.75 | 0.47 | 0.39 | 0.50 | 0.66 | 1.44 | 0.00 | 1.44 | 0.00 |
Operating CF/Net income |
3.28 | (1.07) | (0.10) | 0.09 | 1.19 | 4.38 | 5.94 | (2.51) | 0.00 | (1.59) |
Capex/Depreciation |
(0.05) | (0.02) | (0.13) | (0.03) | (0.39) | (0.58) | (0.08) | (0.08) | 0.00 | — |
Interest Coverage |
2.04 | (0.39) | (2.01) | (13.91) | 10.85 | 2.18 | 1.45 | 1.33 | 1.33 | 1.87 |
| 10.98% | (17.76%) | (49.34%) | (33.55%) | 5.72% | 11.33% | 4.71% | (12.49%) | 0.00% | 0.00% | |
| 3.22% | (4.70%) | (14.31%) | (12.21%) | 2.25% | 3.39% | 2.90% | 0.00% | (8.12%) | 0.00% | |
ROIC |
7.16% | (1.98%) | (8.82%) | (13.06%) | 0.89% | 5.40% | 6.99% | 10.49% | 0.00% | — |
Return on Tangible Assets |
16.92% | (39.17%) | (121.01%) | 3,981.54% | 18.41% | 17.08% | 6.95% | (20.44%) | 0.00% | 0.00% |
Average Days of Receivables |
82.44 | 81.11 | 87.48 | 97.14 | 105.85 | 100.33 | 91.35 | 83.48 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
2.13% | 2.43% | 2.62% | 4.66% | 4.42% | 3.49% | 3.25% | 2.54% | 2.54% | 2.88% |
Selling, General and Administrative Expense of Revenue |
55.28% | 59.97% | 59.31% | 64.86% | 59.01% | 60.12% | 58.35% | 60.05% | 60.05% | 58.40% |
Intangible Assets out of Total Assets |
0.55 | 0.57 | 0.60 | 0.47 | 0.69 | 0.49 | 0.56 | 0.00 | 0.00 | — |
Share Based Compensation of Revenue |
2.23% | 2.32% | 0.53% | 3.43% | 4.61% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.37) | (0.39) | (0.98) | (4.29) | (0.65) | (1.47) | (1.47) | (1.47) | (1.47) | (1.47) |
Graham Number |
5.12 | 0.00 | 0.00 | 0.00 | 10.86 | 24.09 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
4.57% | (4.86%) | (48.00%) | (98.85%) | 3.08% | 4.56% | 4.56% | 4.56% | 4.56% | 4.56% |
Free Cash Flow Yield |
14.55% | 5.58% | 2.43% | (9.37%) | 1.44% | 71.93% | 71.93% | 71.93% | 71.93% | 71.93% |
Revenue per Share |
8.53 | 8.88 | 8.18 | 8.34 | 9.48 | 5.65 | 5.99 | 65.14 | 65.14 | 4.83 |
Operating CF per Share |
1.12 | 0.60 | 0.24 | (0.22) | 0.51 | 1.26 | 0.72 | 9.22 | 0.00 | 0.65 |
Capex per Share |
(0.04) | (0.02) | (0.12) | (0.02) | (0.30) | (0.29) | (0.04) | (0.52) | 0.00 | 0.00 |
Free Cash Flow per Share |
1.08 | 0.59 | 0.13 | (0.24) | 0.21 | 0.97 | 0.68 | 8.70 | 0.00 | 0.65 |
Cash per Share |
0.77 | 0.64 | 0.59 | 0.49 | 1.08 | 1.53 | 1.14 | 8.78 | 0.00 | 0.00 |
Shareholders Equity per Share |
3.43 | 2.88 | 3.53 | 6.71 | 11.74 | 2.54 | 2.56 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.43 | 2.88 | 3.53 | 6.71 | 11.74 | 2.54 | 2.56 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
72.11 | 37.79 | 7.98 | (15.01) | 9.47 | 55.22 | 38.37 | 42.63 | 0.00 | 37.15 |
Working Capital |
112.46 | 65.21 | 92.50 | (31.44) | 82.24 | 89.21 | 94.02 | 83.00 | — | — |
Capital Expenditures |
(2.56) | (1.01) | (7.36) | (1.48) | (13.52) | (16.58) | (2.34) | (2.56) | 0.00 | — |
Net Current Asset Value |
(182.27) | (266.74) | (321.79) | (687.85) | (428.97) | (138.51) | (143.76) | 148.00 | 0.00 | — |
EV/EBIT |
13.68 | 0.00 | 0.00 | 0.00 | 80.21 | 9.21 | 9.21 | 9.21 | 9.21 | 9.21 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | 0.03 | 0.05 | 0.01 | 0.01 | 0.00 | 0.00 |
Price to Operating Income |
9.18 | 0.00 | 0.00 | 0.00 | 54.63 | 4.43 | 4.43 | 4.43 | 4.43 | 4.43 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
2.15 | 1.83 | 1.57 | 2.02 | 1.52 | 4.16 | 6.75 | 6.18 | 0.00 | — |
Cash ROIC |
12.57% | 6.71% | 1.22% | (1.74%) | 1.01% | 13.17% | 9.40% | 17.91% | 0.00% | 0.00% |
Accounts Receivable Turnover |
4.44 | 4.58 | 3.96 | 3.92 | 4.04 | 3.70 | 4.30 | 4.04 | 0.00 | 0.00 |
Accounts Payable Turnover |
10.40 | 7.92 | 6.17 | 6.75 | 12.02 | 16.14 | 12.59 | 12.02 | 0.00 | 0.00 |
Inventory Turnover |
2.06 | 2.01 | 2.09 | 2.47 | 2.82 | 3.11 | 3.35 | 3.12 | 0.00 | 0.00 |
Average Days of Payables |
22.17 | 46.73 | 45.66 | 73.99 | 48.16 | 18.42 | 25.85 | 34.69 | 0.00 | 0.00 |
Days of Inventory on Hand |
166.82 | 182.40 | 181.03 | 170.90 | 175.64 | 121.28 | 109.68 | 117.09 | 0.00 | 0.00 |
Average Receivables |
127.85 | 125.09 | 129.54 | 130.63 | 106.62 | 86.71 | 79.06 | 79.00 | — | — |
Average Payables |
17.31 | 23.36 | 29.87 | 26.81 | 10.67 | 5.43 | 7.22 | 7.00 | — | — |
Average Inventory |
87.36 | 91.90 | 88.05 | 73.23 | 45.40 | 28.22 | 27.16 | 27.00 | — | — |
Average Assets |
705.76 | 769.43 | 1,091.78 | 1,299.26 | 860.16 | 483.44 | 236.20 | 0.00 | 221.50 | — |
Average Common Equity |
207.03 | 203.36 | 316.67 | 473.01 | 338.97 | 144.89 | 145.31 | 144.00 | — | — |
Columns are period end dates